Position in RARE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,543,426
+$3,993,870 QoQ
Shares Held
315,766
+1.0% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. RARE ranks #72 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,543,426 | 315,766 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,549,556 | 312,628 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,108,426 | 309,062 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $20,369,693 | 677,184 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,276,671 | 475,156 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $21,742,149 | 600,446 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,978,992 | 427,359 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,160,061 | 218,903 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $12,079,042 | 293,894 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,081,117 | 215,916 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,268,770 | 214,738 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,759,025 | 189,594 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,285,777 | 179,618 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,197,628 | 179,492 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,389,992 | 181,092 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,386,011 | 178,363 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,690,892 | 179,197 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $13,013,285 | 179,197 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,069,852 | 179,211 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $18,259,956 | 202,461 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $19,297,409 | 202,385 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $23,048,338 | 202,427 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $35,172,016 | 254,078 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $31,464,550 | 382,827 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $29,917,038 | 382,473 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $16,993,275 | 382,473 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||